journal article·2024-05

A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy

Xiaokang Zhu, Li Xie, Jinming Tian, Yang Jiang, Erqun Song, Yang Song

Acta Biomaterialia· Volume 180
Publisher page

Abstract

Ferroptosis has emerged as a promising strategy for treating triple-negative breast cancer (TNBC) due to bypassing apoptosis and triggering immunogenic cell death (ICD) of tumor cells. However, the antitumor efficacy has been limited by the insufficient intracellular ferrous iron concentration required for ferroptosis and inadequate antitumor immune response. To address these limitations, we designed a multi-mode nano-platform (MP-FA@R-F NPs), which exhibited a synergistic effect of ferroptosis, apoptosis and induced immune response for enhanced antitumor therapy. MP-FA@R-F NPs target folate receptors, which are over-expressed on the tumor cell's surface to promote intracellular uptake. The cargoes, including Rhein and Fe3O4, would be released in intracellular acid, accelerating by NIR laser irradiation. The released Rhein induced apoptosis of tumor cells mediated by the caspase 3 signal pathway, while the released Fe3O4 triggered ferroptosis through the Fenton reaction and endowed the nanoplatform with magnetic resonance imaging (MRI) capabilities. In addition, ferroptosis-dying tumor cells could release damage-associated molecular patterns (DAMPs) to promote T cell activation and infiltration for immune response and induce immunogenic cell death (ICD) for tumor immunotherapy. Together, MP-FA@R-F NPs represent a potential synergistic ferro-/chemo-/immuno-therapy strategy with MRI guidance for enhanced antitumor therapy. STATEMENT OF SIGNIFICANCE: The massive strategies of cancer therapy based on ferroptosis have been emerging in recent years, which provided new insights into designing materials for cancer therapy. However, the antitumor efficacy of ferroptosis is still unsatisfactory, mainly due to insufficient intracellular pro-ferroptotic stimuli. In the current study, we designed a multi-mode nano-platform (MP-FA@R-F NPs), which represented a potential synergistic ferro-/chemo-/immuno-therapy strategy with MRI guidance for enhanced antitumor therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Nanoplatforms for cancer theranostics · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Ternary alloy PtWMn as a Mn nanoreservoir for high-field MRI monitoring and highly selective ferroptosis therapy10.1002/anie.202117229 ↗
2. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis10.1038/s41467-022-35059-x ↗
3. Ferroptosis: a novel anti-tumor action for cisplatin10.4143/crt.2016.572 ↗
4. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice10.1038/ncb3064 ↗
5. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion10.1038/s41568-019-0149-1 ↗
6. Correction to self-adaptive single-atom catalyst boosting selective ferroptosis in tumor cells10.1021/acsnano.2c08004 ↗
7. Cysteine depletion induces pancreatic tumor ferroptosis in mice10.1126/science.aaw9872 ↗
8. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors10.1021/acsnano.8b06201 ↗
9. Ferroptosis: mechanisms, biology and role in disease10.1038/s41580-020-00324-8 ↗
10. The chemical basis of ferroptosis10.1038/s41589-019-0408-1 ↗
11. Broadening horizons: the role of ferroptosis in cancer10.1038/s41571-020-00462-0 ↗
12. Ferroptosis at the intersection of lipid metabolism and cellular signaling10.1016/j.molcel.2022.03.022 ↗
13. Degradable magnetic nanoplatform with hydroxide ions triggered photoacoustic, mr imaging, and photothermal conversion for precise cancer theranostic10.1021/acs.nanolett.1c04804 ↗
14. Ferrous-supply-regeneration nanoengineering for cancer-cell-specific ferroptosis in combination with imaging-guided photodynamic therapy10.1021/acsnano.8b05860 ↗
15. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics10.1021/acsnano.8b06399 ↗
16. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer10.1158/0008-5472.CAN-20-3477 ↗
17. Editorial for the special issue "Microplastics in aquatic environments: occurrence, distribution and effects"
18. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis
19. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment10.1016/j.biomaterials.2022.121832 ↗
20. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity10.1136/jitc-2020-001369 ↗
21. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy10.1038/s41586-019-1170-y ↗
22. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity10.1038/s41467-022-31218-2 ↗
23. Biomimetic nanoparticles carrying a repolarization agent of tumor-associated macrophages for remodeling of the inflammatory microenvironment following photothermal therapy10.1021/acsnano.1c05618 ↗
24. Recent Advances in hyperthermia therapy-based synergistic immunotherapy10.1002/adma.202004788 ↗
25. Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy10.7150/thno.71693 ↗
26. Detection of glucose based on noble metal nanozymes: mechanism, activity regulation, and enantioselective recognition10.1002/smll.202205924 ↗
27. Bioorthogonal-activated in situ vaccine mediated by a COF-based catalytic platform for potent cancer immunotherapy10.1021/jacs.2c13010 ↗
28. Versatile nanoemulsion assembly approach to synthesize functional mesoporous carbon nanospheres with tunable pore sizes and architectures10.1021/jacs.9b02091 ↗
29. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe(3+) as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer
30. Remodeling tumor-associated neutrophils to enhance dendritic cell-based HCC neoantigen nano-vaccine efficiency10.1002/advs.202105631 ↗
31. Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: a prove-of-concept study of "sword and shield" theory
32. Casp3/7-Instructed Intracellular Aggregation of Fe3O4 Nanoparticles Enhances T2 MR Imaging of Tumor Apoptosis10.1021/acs.nanolett.6b00331 ↗
33. Combined photothermal-photodynamic therapy by indocyanine green loaded polydopamine nanoparticles enhances anti-mammary gland tumor efficacy10.1039/D2TB00565D ↗
34. Intelligent MoS(2)-CuO heterostructures with multiplexed imaging and remarkably enhanced antitumor efficacy via synergetic photothermal therapy/chemodynamic therapy/ immunotherapy10.1016/j.biomaterials.2020.120545 ↗
35. R. Yue, C. Zhang, L.J.C. Xu, Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy, (2022).10.1016/j.chempr.2022.03.009 ↗
36. Real-time imaging of free radicals for mitochondria-targeting hypoxic tumor therapy10.1021/acs.nanolett.8b02670 ↗
37. Metabolomic profiling of single enlarged lysosomes10.1038/s41592-021-01182-8 ↗
38. Molecular engineering of pH-responsive NIR oxazine assemblies for evoking tumor ferroptosis via triggering lysosomal dysfunction10.1021/jacs.2c13222 ↗
39. NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest10.1093/nar/gkaa631 ↗
40. miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia10.1016/j.redox.2019.101402 ↗
41. Ferroptosis: death by lipid peroxidation10.1016/j.tcb.2015.10.014 ↗
42. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy10.1016/j.actbio.2022.04.024 ↗
43. Intracellular photoactivation of caspase-3 by molecular glues for spatiotemporal apoptosis induction10.1021/jacs.0c01823 ↗
44. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
45. Novel anthraquinone compounds induce cancer cell death through paraptosis10.1021/acsmedchemlett.8b00624 ↗
46. Interrelation between programmed cell death and immunogenic cell death: take antitumor nanodrug as an example10.1002/smtd.202201406 ↗
47. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation10.1016/j.immuni.2019.03.020 ↗
48. Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma10.1016/j.ymthe.2022.09.012 ↗
49. Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles10.1039/C5NR05264E ↗
50. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications10.1016/j.addr.2019.07.006 ↗